LONDON

伦敦

,

，

May 7, 2026

2026年5月7日

/PRNewswire/ -- BioPhorum has acquired PharmaX Solutions, a consultancy specialising in digital transformation and end-to-end digital manufacturing solutions across pharmaceutical manufacturing and production environments.

/PRNewswire/ -- BioPhorum收购了PharmaX Solutions，这是一家专注于数字转型以及在制药生产与制造环境中提供端到端数字制造解决方案的咨询公司。

The acquisition strengthens BioPhorum's Implementation Services offering and boosts the value the organisation brings to its customers and the wider industry in driving efficiency, transformation and improvement. Combining BioPhorum's well-respected, collaborative best practice guidance with PharmaX's deep implementation expertise enables delivery of practical, operational solutions at scale..

此次收购增强了BioPhorum的实施服务产品，并提升了该组织为客户及整个行业带来的价值，推动效率、转型和改进。通过将BioPhorum备受推崇的协作最佳实践指导与PharmaX深厚的实施专业知识相结合，能够大规模提供实用且可操作的解决方案。

PharmaX Solutions specialises in the design, implementation, and integration of digital manufacturing systems, including MES, automation platforms, and quality systems, with deep expertise in GxP-regulated environments and IT/OT convergence. Adding PharmaX Solutions into the BioPhorum group of companies further expands the organisation's international footprint across the sector.

PharmaX Solutions 专注于数字制造系统的设计、实施和集成，包括制造执行系统 (MES)、自动化平台和质量系统，在 GxP 监管环境和 IT/OT 融合方面拥有深厚的专业知识。将 PharmaX Solutions 纳入 BioPhorum 集团进一步扩大了该组织在行业中的国际影响力。

PharmaX Solutions operates with a team of 50 skilled professionals across four international offices located in Germany, Spain, Denmark, and Switzerland..

PharmaX Solutions 在德国、西班牙、丹麦和瑞士设有四个国际办事处，拥有 50 名专业人员组成的团队。

Through this acquisition, BioPhorum's core capabilities now provide a comprehensive end-to-end service spanning knowledge sharing, best practice guidance, training, and hands-on practitioner-led implementation.

通过此次收购，BioPhorum 的核心能力现在提供涵盖知识共享、最佳实践指导、培训和实践者主导的实施的全面端到端服务。

This strategic move is part of BioPhorum's broader growth journey, deepening the value it provides to the Life Sciences industry. Over the past 18 months, BioPhorum has expanded its global portfolio by acquiring specialist training companies Brookwood Global, Compliance Hub and Inspired Pharma.

这一战略举措是BioPhorum更广泛增长历程的一部分，深化了其为生命科学行业提供的价值。在过去的18个月里，BioPhorum通过收购专业培训公司Brookwood Global、Compliance Hub和Inspired Pharma，扩展了其全球业务组合。

'We are delighted to welcome PharmaX Solutions into BioPhorum' said Deborah Kobewka, CEO of BioPhorum. 'Our organisation is on an exciting growth trajectory, as demonstrated by our recent expansions in the training sector. Strengthening our Implementation Services offering with the addition of PharmaX perfectly complements this growth.

“我们非常高兴欢迎PharmaX解决方案加入BioPhorum，”BioPhorum首席执行官Deborah Kobewka表示。“我们的组织正处于令人兴奋的增长轨道上，我们最近在培训领域的扩展就证明了这一点。通过增加PharmaX来加强我们的实施服务，完全符合这一增长。”

Their deep expertise in digital manufacturing will directly benefit our customers and the wider life sciences community, helping them effectively embed our best practices to drive real, sustainable improvements in their operations, and ultimately accelerating the safe delivery of lifesaving medicines to patients.'.

他们在数字制造方面的深厚专业知识将直接使我们的客户和更广泛的生命科学界受益，帮助他们有效地融入我们的最佳实践，以推动其运营中实现真正可持续的改进，最终加速向患者安全交付挽救生命的药物。

Karthik Kuncharam, Founder and CEO of PharmaX Solutions, commented: 'We are delighted to be joining the BioPhorum group. Our team has always been dedicated to supporting pharmaceutical manufacturers in designing and implementing digital manufacturing systems that are both operationally effective and fully compliant with regulatory requirements.

Karthik Kuncharam，PharmaX Solutions的创始人兼首席执行官评论道：“我们很高兴加入BioPhorum集团。我们的团队一直致力于支持制药制造商设计和实施既操作高效又完全符合监管要求的数字化制造系统。”

By combining our hands-on consulting experience with BioPhorum's extensive network and industry-leading guidance, we are in a much stronger position to help global manufacturers optimise production and uphold the highest regulatory standards.'.

通过将我们亲身实践的咨询经验与BioPhorum广泛的网络和行业领先的指导相结合，我们能够更有力地帮助全球制造商优化生产，并坚持最高的监管标准。

Kunal Pandit, Partner at Five Arrows, the alternative assets arm of Rothschild & Co,  an investor in BioPhorum, added: 'BioPhorum's acquisition of PharmaX Solutions marks a true milestone and a step-change in the capabilities of the organisation. As investors, we view this move as highly strategic, accelerating the evolution of BioPhorum's business model from a Phorum-led entity to a broader, diversified platform.

五箭资本（Rothschild & Co旗下另类资产部门）合伙人、BioPhorum的投资者Kunal Pandit补充道：“BioPhorum收购PharmaX Solutions标志着一个真正的里程碑，也是该组织能力的一次飞跃。作为投资者，我们认为此举具有高度战略性，加速了BioPhorum商业模式从论坛主导实体向更广泛、多元化的平台转型。”

The ability to translate industry best practice insights into practical, operational execution for global manufacturers significantly expands its addressable market and long-term growth potential.'.

将行业最佳实践见解转化为全球制造商的实际操作执行的能力，极大地扩展了其可触及的市场和长期增长潜力。

Notes to Editors:

编辑须知：

Media Contact:

媒体联系人：

[email protected]

[email protected]

About BioPhorum:

关于BioPhorum：

BioPhorum enables the global biopharmaceutical industry to connect, collaborate, and accelerate progress for the benefit of all. Founded in 2004, BioPhorum has evolved from an end user forum into a globally trusted, industry led organisation that brings together senior leaders and subject matter experts from across the biopharma value chain..

BioPhorum助力全球生物制药行业连接、协作并加速发展，以造福所有人。BioPhorum成立于2004年，已从一个终端用户论坛发展为一个全球信赖的、由行业主导的组织，汇聚了来自生物制药价值链各环节的高层领导者和主题专家。

Through its established Phorums and communities, BioPhorum provides a non-competitive, trusted environment where members openly share challenges, develop peer led best practices, and produce influential thought leadership that shapes industry standards.

通过其已建立的Phorums和社区，BioPhorum提供了一个非竞争性的、可信赖的环境，成员在此公开分享挑战，发展由同行主导的最佳实践，并产出影响行业标准的思想领导力。

Building on this collaborative foundation, BioPhorum has expanded its offering to include BioPhorum Implementation Services and BioPhorum Training, enabling organisations to translate collective insight into real world impact. These services help leaders accelerate strategic change, strengthen enterprise capability, and embed proven, practitioner led approaches across manufacturing, quality, supply chain, and digital transformation..

基于这一协作基础，BioPhorum扩展了其服务内容，包括BioPhorum实施服务和BioPhorum培训，帮助组织将集体洞察转化为现实影响。这些服务协助领导者加速战略变革，增强企业能力，并在制造、质量、供应链和数字化转型领域中嵌入经过验证的、由实践者主导的方法。

Supported by recent strategic acquisitions, BioPhorum is expanding both the breadth and depth of its offerings to meet the evolving needs of the global pharmaceutical industry. This continued growth strengthens BioPhorum's ability to help organisations move from collaboration to execution, navigate complexity, implement change effectively, and strengthen long term operational performance..

在近期战略收购的支持下，BioPhorum正在扩展其产品和服务的广度与深度，以满足全球制药行业不断变化的需求。这一持续增长增强了BioPhorum帮助组织从协作走向执行、应对复杂性、有效实施变革并提升长期运营绩效的能力。

https://www.biophorum.com/

https://www.biophorum.com/

About PharmaX Solutions:

关于PharmaX解决方案：

PharmaX Solutions is a specialist consultancy focused on delivering digital manufacturing and system implementation services for the pharmaceutical and life sciences industry.

PharmaX Solutions 是一家专注于为制药和生命科学行业提供数字制造和系统实施服务的专业咨询公司。

The company provides end-to-end support across MES, automation, IT quality & compliance, serialisation, analytics and IT/OT integration, with deep expertise in GxP-regulated environments. PharmaX works hands-on with manufacturers to design, implement, and integrate compliant digital solutions that enhance operational efficiency, data integrity, and production performance..

公司提供涵盖MES、自动化、IT质量与合规、序列化、分析以及IT/OT集成的端到端支持，并在GxP监管环境下拥有深厚的专业知识。PharmaX与制造商紧密合作，设计、实施和集成符合规范的数字解决方案，以提高运营效率、数据完整性和生产性能。

Its practitioner-led approach combines technical depth with operational understanding of pharmaceutical manufacturing processes.

其以从业者为主导的方法结合了技术深度与对制药生产流程的操作理解。

www.pharmaxsolutions.com

www.pharmaxsolutions.com

About Five Arrows:

关于五箭：

Five Arrows is the alternative assets arm of Rothschild & Co and has €33 billion AuM with offices in Paris, London, New York, Los Angeles, San Francisco and Luxembourg. This includes a series of funds dedicated to corporate and secondary private equity, multi-managers funds and co-investments, as well as senior and junior credits..

五箭资本是罗斯柴尔德集团的另类资产部门，管理着330亿欧元的资产，其办公室位于巴黎、伦敦、纽约、洛杉矶、旧金山和卢森堡。该部门旗下拥有一系列基金，专注于企业私募股权、二级市场私募股权、多管理人基金及联合投资，同时还涉及高级和次级信贷业务。

With €13 billion of assets under management, the corporate private equity business of Five Arrows is focused on investing in companies with sustainable and durable barriers to entry; strong management teams; business models with high visibility of organic unit volume growth and strong unit economics; and multiple operational levers that can be used to unlock latent value.

管理着130亿欧元资产的五箭企业私募股权业务，专注于投资那些拥有可持续且持久进入壁垒的公司；强大的管理团队；具有高可见度有机单位增长和强劲单位经济效益的商业模式；以及可用来释放潜在价值的多重运营杠杆。

Sectors are limited to healthcare, data and software and technology–enabled business services..

部门仅限于医疗保健、数据和软件以及技术驱动的商业服务。

For more information, please visit

更多信息，请访问

www.rothschildandco.com/en/five-arrows/corporate-private-equity

www.rothschildandco.com/zh/five-arrows/corporate-private-equity

Logo -

标志 -

https://mma.prnewswire.com/media/2876942/BioPhorum_Logo.jpg

https://mma.prnewswire.com/media/2876942/BioPhorum_Logo.jpg

SOURCE BioPhorum

来源：BioPhorum

21

21

%

%

more press release views with

更多新闻稿浏览量与

Request a Demo

请求演示